Correlation between levels of lipoprotein (a) and disease activity score in patients with rheumatoid arthritis

Pain Clinic

Volumn 16, Issue 1, 2004, Pages 53-58

  Taysi, Seyithan ^a   Bakan, Ebubekir ^a   Kuskay, Sevinc ^a   Sari, Refik Ali ^a   Bakan, Nuri ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Cholesterol; Disease activity score; Lipoprotein (a); Rheumatoid arthritis; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONSTEROID ANTIINFLAMMATORY AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; RHEUMATOID ARTHRITIS;

EID: 1542619407     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856904322858701     Document Type: Article

References (37)

1. Harris ED, Clinical features of rheumatoid arthritis, in: Textbook of Rheumatology, Kelley WN, Ruddy Harris ED, Sledge CB (Eds), pp. 898-932. W.B. Saunders, Philadelphia (1997).
2. Harris ED, Rheumatoid arthritis: pathophysiology and implications for therapy, New Engl J Med 322, 1277-89 (1990).
3. Hochberg MC, Adult and juvenile rheumatoid arthritis: current epidemiologic concepts, Epidemiol Rev 3, 27-44 (1981).
4. Taysi S, Polat MF, Gul M, et al., Lipid peroxidation, some extracellular antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis, Rheumatol Int 21, 200-4 (2002).
5. Taysi S, Gulcin I, Sari RA, et al., Trace elements and disease activity score in patients with rheumatoid arthritis, The Pain Clinic 15, 435-39 (2003).
6. Taysi S, Umudum Z, Sari RA, et al., Nitric oxide level and superoxide dismutase activity in serum of the patients with rheumatoid arthritis, The Pain Clinic 15, 429-34 (2003).
7. Busso N, Dudler J, Salvi R, et al., Plasma apolipoprotein (a) Co-deposits with fibrin in inflammatory arthritis joints, Am J Pathol 159, 1445-53 (2001).
8. Berg K, A new serum system in man - the Lp system, Acta Pathol Microbiol Scand 59, 367-82 (1963).
9. Min WK, Lee JO, Huh JW, Relation between lipoprotein (a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease, Clin Chem 43, 1891-5 (1997).
10. Wityk RJ, Kittner SJ, Jenner JL, et al., Lipoprotein (a) and the risk of ischemic stroke in young women, Atherosclerosis 150, 389-96 (2000).
11. Rath M, Niendorf A, Reblin T, et al., Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients, Atherosclerosis 9, 579-92 (1989).
12. Niendorf A, Rath M, Wolf K, et al., Morphological detection and quantification of lipoprotein (a) deposition in atheromatous lesions of human aorta and coronary arteries, Virchows Arch A Pathol Anat Histopathol 417, 105-11 (1990).
13. Busso N, Peclat V, So A, et al., Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints, Ann Rheum Dis 56, 550-7 (1997).
14. Walsh DA, Angiogenesis and arthritis, Rheumatology 38, 103-12 (1999).
15. Seriolo B, Accardo S, Fasciolo D, et al., Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis, Clin Exp Rheumatol 14, 593-9 (1996).
16. Asanuma Y, Kawai S, Aoshima H, et al., Serum lipoprotein (a) and apolipoprotein (a) phenotypes in patients with rheumatoid arthritis, Arthritis Rheum 42 (3), 443-447 (1999).
17. Orem A, Deger O, Cimsit G, et al., Plasma Lipoprotein (a) and its relationship with disease activity in patients with Behcet's disease, Eur J Clin Chem Clin Biochem 33, 473-8 (1995).
18. van der Heijde DMFM, van't Hof MA, van Riel PLCM, Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score, Ann Rheum Dis 49, 916-20 (1990).
19. van Riel PLCM, van Gestel AM, van de Putte LBA, Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers, Br J Rheumatol 35 (Suppl. 2), 4-7 (1996).
20. Sari RA, Taysi S, Erdem F, et al., Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus, Rheumatol Int 21, 149-52 (2002).
21. Pemi P, Genovese M, Eugk E, et al., Definition, incidence and clinical description of flare in systemic lupus erythematosus, Arthritis Rheum 34, 937-43 (1991).
22. Çoǧalgil Ş, Taysi S, Sialic acid, intercellular adhesion molecule-1 and rheumatoid arthritis: a study on the erythrocyte membrane, Clin Chem Lab Med 40, 356-60 (2002).
23. Örem A, Deǧer O, Önder E, et al., Distribution of serum lipoprotein (a) concentrations in a healthy Turkish population, Ann Clin Biochem 31, 343-6 (1994).
24. Loscalzo J, Lipoprotein (a): a unique risk factor for atherothrombotic disease, Arteriosclerosis 10, 672-9 (1990).
25. Borba EF, Santos RD, Bonfa E, et al., Lipoprotein (a) levels in systemic lupus erythematosus, J Rheumatol 21, 220-3 (1994).
26. Okawa-Takatsuji M, Aotsuka S, Sumiya M, et al., Clinical significance of the serum lipoprotein (a) level in the patients with systemic lupus erythematosus: its elevation during disease flare, Clin Exp Rheumatol 14, 531-6 (1996).
27. Park YB, Lee SK, Lee WK, et al., Lipid profiles in patients with rheumatoid arthritis, J Rheumatol 26, 1701-4 (1999).
28. Sari RA, Polat MF, Taysi S, et al., Serum lipoprotein (a) level and its clinical significance in patients with systemic lupus erythematosus, Clin Rheumatol. 21, 520-4 (2002).
29. Lee YH, Choi SJ, Ji JD, et al., Lipoprotein (a) and lipids in relation to inflammation in rheumatoid arthritis, Clin Rheumatol 19, 324-5 (2002).
30. Asanuma Y, Kawai S, Apolipoprotein (a) deposition in atherosclerotic coronary artheries of a patient with systemic lupus erythematosus: comment on the article by Romero et al., Arthritis Rheum 43, 2141-2 (2000).
31. Kawai S, Mizushima Y, Kaburaki J, Increased serum lipoprotein (a) levels in systemic lupus erythematosus with myocardial and cerebral infarctions [letter], J Rheumatol 22, 1210-1 (1994).
32. Roberts WC, Atherosclerotic risk factors: are there ten or is there only one? Am J Cardiol 64, 552-4 (1989).
33. Castelli WP, The triglyceride issue: a view from Framingham, Am Heart J 112, 432-7 (1986).
34. Miller NE, HDL metabolism and its role in lipid transport, Eur Heart J 11 (Suppl.), 1-3 (1990).
35. Köse K, Kardaş Y, Doǧan P, The lipid parameters in patients with rheumatoid arthritis, Doǧa-Tr J of Medical Sciences 198, 25-30 (1993).
36. Lakatos J, Harsagyi A, Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis, Clin Biochem 21, 93-6 (1988).
37. Örem A, Efe H, Deǧer O, et al., Relationship between lipid peroxidation and disease activity in patients with Behçet's disease, J Dermatol Sci 16, 11-6 (1997).